{"id":3678,"date":"2025-08-06T19:22:23","date_gmt":"2025-08-06T19:22:23","guid":{"rendered":"https:\/\/vantagebiotrials.com\/?p=3678"},"modified":"2026-02-10T20:01:45","modified_gmt":"2026-02-10T20:01:45","slug":"medtech-canada-october-2-2025","status":"publish","type":"post","link":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/","title":{"rendered":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025"},"content":{"rendered":"<p data-start=\"251\" data-end=\"537\">Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands.<\/p>\n<p data-start=\"539\" data-end=\"804\">Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and his co-presenter Marie-Claude Gravel, President of SPharm, as they explore the regulatory and clinical hurdles sponsors face when initiating investigational device studies in Canada\u2014and how to overcome them.<\/p>\n<p data-start=\"806\" data-end=\"953\">This webinar is a must-attend for industry sponsors, clinical teams, and regulatory professionals navigating the Canadian medical device landscape.<\/p>\n<p data-start=\"955\" data-end=\"1077\">For more information on how Vantage BioTrials can support your next trial, contact us at <a class=\"cursor-pointer\" rel=\"noopener\" data-start=\"1049\" data-end=\"1074\">info@vantagebiotrials.com<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and his co-presenter Marie-Claude Gravel, President of SPharm, as they explore the regulatory and clinical hurdles sponsors face when initiating investigational device studies in Canada\u2014and how to overcome them. This webinar is a must-attend for industry sponsors, clinical teams, and regulatory professionals navigating the Canadian medical device landscape. For more information on how Vantage BioTrials can support your next trial, contact us at info@vantagebiotrials.com.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"iawp_total_views":30,"footnotes":""},"categories":[72],"tags":[],"class_list":["post-3678","post","type-post","status-publish","format-standard","hentry","category-archive-events-en","cms-no-post-thumbnail"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Vantage BioTrials\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_CA\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Vantage Biotrials - Contract Research Organization (CRO) implementing Risk-Based Management through the use of Quality by Design (Qbd) methodologies.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials\" \/>\n\t\t<meta property=\"og:description\" content=\"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"305\" \/>\n\t\t<meta property=\"og:image:height\" content=\"130\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-08-06T19:22:23+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-02-10T20:01:45+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@VantageBT\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@VantageBT\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#blogposting\",\"name\":\"Upcoming Webinar \\u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials\",\"headline\":\"Upcoming Webinar \\u2013 Navigating Medical Device Trials in Canada | October 2, 2025\",\"author\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/author\\\/vikenadmin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/vantagebiotrials.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/logo-post.png\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/#articleImage\",\"width\":305,\"height\":130},\"datePublished\":\"2025-08-06T19:22:23+00:00\",\"dateModified\":\"2026-02-10T20:01:45+00:00\",\"inLanguage\":\"fr-CA\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#webpage\"},\"articleSection\":\"archive-events-EN, English, pll_6893a41fced89\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/category\\\/archive-events-en\\\/#listItem\",\"name\":\"archive-events-EN\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/category\\\/archive-events-en\\\/#listItem\",\"position\":2,\"name\":\"archive-events-EN\",\"item\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/category\\\/archive-events-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#listItem\",\"name\":\"Upcoming Webinar \\u2013 Navigating Medical Device Trials in Canada | October 2, 2025\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#listItem\",\"position\":3,\"name\":\"Upcoming Webinar \\u2013 Navigating Medical Device Trials in Canada | October 2, 2025\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/category\\\/archive-events-en\\\/#listItem\",\"name\":\"archive-events-EN\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/#organization\",\"name\":\"Vantage Biotrials\",\"description\":\"Contract Research Organization (CRO) implementing Risk-Based Management through the use of Quality by Design (Qbd) methodologies.\",\"url\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/\",\"telephone\":\"+15145643466\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/vantagebiotrials.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/logo-post.png\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#organizationLogo\",\"width\":305,\"height\":130},\"image\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/VantageBT\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/vantage-biotrials-inc-\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/author\\\/vikenadmin\\\/#author\",\"url\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/author\\\/vikenadmin\\\/\",\"name\":\"Vantage BioTrials\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#webpage\",\"url\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/\",\"name\":\"Upcoming Webinar \\u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials\",\"description\":\"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\\u2013IV devices\\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and\",\"inLanguage\":\"fr-CA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/medtech-canada-october-2-2025\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/author\\\/vikenadmin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/author\\\/vikenadmin\\\/#author\"},\"datePublished\":\"2025-08-06T19:22:23+00:00\",\"dateModified\":\"2026-02-10T20:01:45+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/\",\"name\":\"Vantage Biotrials\",\"description\":\"Contract Research Organization (CRO) implementing Risk-Based Management through the use of Quality by Design (Qbd) methodologies.\",\"inLanguage\":\"fr-CA\",\"publisher\":{\"@id\":\"https:\\\/\\\/vantagebiotrials.com\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials","description":"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and","canonical_url":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#blogposting","name":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials","headline":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025","author":{"@id":"https:\/\/vantagebiotrials.com\/fr\/author\/vikenadmin\/#author"},"publisher":{"@id":"https:\/\/vantagebiotrials.com\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png","@id":"https:\/\/vantagebiotrials.com\/fr\/#articleImage","width":305,"height":130},"datePublished":"2025-08-06T19:22:23+00:00","dateModified":"2026-02-10T20:01:45+00:00","inLanguage":"fr-CA","mainEntityOfPage":{"@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#webpage"},"isPartOf":{"@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#webpage"},"articleSection":"archive-events-EN, English, pll_6893a41fced89"},{"@type":"BreadcrumbList","@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/vantagebiotrials.com\/fr#listItem","position":1,"name":"Home","item":"https:\/\/vantagebiotrials.com\/fr","nextItem":{"@type":"ListItem","@id":"https:\/\/vantagebiotrials.com\/fr\/category\/archive-events-en\/#listItem","name":"archive-events-EN"}},{"@type":"ListItem","@id":"https:\/\/vantagebiotrials.com\/fr\/category\/archive-events-en\/#listItem","position":2,"name":"archive-events-EN","item":"https:\/\/vantagebiotrials.com\/fr\/category\/archive-events-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#listItem","name":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025"},"previousItem":{"@type":"ListItem","@id":"https:\/\/vantagebiotrials.com\/fr#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#listItem","position":3,"name":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025","previousItem":{"@type":"ListItem","@id":"https:\/\/vantagebiotrials.com\/fr\/category\/archive-events-en\/#listItem","name":"archive-events-EN"}}]},{"@type":"Organization","@id":"https:\/\/vantagebiotrials.com\/fr\/#organization","name":"Vantage Biotrials","description":"Contract Research Organization (CRO) implementing Risk-Based Management through the use of Quality by Design (Qbd) methodologies.","url":"https:\/\/vantagebiotrials.com\/fr\/","telephone":"+15145643466","logo":{"@type":"ImageObject","url":"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png","@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#organizationLogo","width":305,"height":130},"image":{"@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#organizationLogo"},"sameAs":["https:\/\/x.com\/VantageBT","https:\/\/www.linkedin.com\/company\/vantage-biotrials-inc-"]},{"@type":"Person","@id":"https:\/\/vantagebiotrials.com\/fr\/author\/vikenadmin\/#author","url":"https:\/\/vantagebiotrials.com\/fr\/author\/vikenadmin\/","name":"Vantage BioTrials"},{"@type":"WebPage","@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#webpage","url":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/","name":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials","description":"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and","inLanguage":"fr-CA","isPartOf":{"@id":"https:\/\/vantagebiotrials.com\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/#breadcrumblist"},"author":{"@id":"https:\/\/vantagebiotrials.com\/fr\/author\/vikenadmin\/#author"},"creator":{"@id":"https:\/\/vantagebiotrials.com\/fr\/author\/vikenadmin\/#author"},"datePublished":"2025-08-06T19:22:23+00:00","dateModified":"2026-02-10T20:01:45+00:00"},{"@type":"WebSite","@id":"https:\/\/vantagebiotrials.com\/fr\/#website","url":"https:\/\/vantagebiotrials.com\/fr\/","name":"Vantage Biotrials","description":"Contract Research Organization (CRO) implementing Risk-Based Management through the use of Quality by Design (Qbd) methodologies.","inLanguage":"fr-CA","publisher":{"@id":"https:\/\/vantagebiotrials.com\/fr\/#organization"}}]},"og:locale":"fr_CA","og:site_name":"Vantage Biotrials - Contract Research Organization (CRO) implementing Risk-Based Management through the use of Quality by Design (Qbd) methodologies.","og:type":"article","og:title":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials","og:description":"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and","og:url":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/","og:image":"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png","og:image:secure_url":"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png","og:image:width":305,"og:image:height":130,"article:published_time":"2025-08-06T19:22:23+00:00","article:modified_time":"2026-02-10T20:01:45+00:00","twitter:card":"summary_large_image","twitter:site":"@VantageBT","twitter:title":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025 - Vantage Biotrials","twitter:description":"Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II\u2013IV devices\u2014but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands. Hosted by Medtech Canada on October 2, 2025, join Vatche Bartekian, President of Vantage BioTrials, and","twitter:creator":"@VantageBT","twitter:image":"https:\/\/vantagebiotrials.com\/wp-content\/uploads\/2023\/11\/logo-post.png"},"aioseo_meta_data":{"post_id":"3678","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-09-27 13:39:43","updated":"2026-02-10 20:02:56","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/vantagebiotrials.com\/fr\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/vantagebiotrials.com\/fr\/category\/archive-events-en\/\" title=\"archive-events-EN\">archive-events-EN<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tUpcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/vantagebiotrials.com\/fr"},{"label":"archive-events-EN","link":"https:\/\/vantagebiotrials.com\/fr\/category\/archive-events-en\/"},{"label":"Upcoming Webinar \u2013 Navigating Medical Device Trials in Canada | October 2, 2025","link":"https:\/\/vantagebiotrials.com\/fr\/medtech-canada-october-2-2025\/"}],"_links":{"self":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/posts\/3678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/comments?post=3678"}],"version-history":[{"count":0,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/posts\/3678\/revisions"}],"wp:attachment":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/media?parent=3678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/categories?post=3678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/tags?post=3678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}